Rita A. Karachun - May 3, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Sr. VP Fince-Global Controller
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Rita Karachun
Stock symbol
MRK
Transactions as of
May 3, 2023
Transactions value $
-$744,702
Form type
4
Date filed
5/5/2023, 04:54 PM
Previous filing
May 4, 2023
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $94.7K +803 +1.8% $117.89 45.4K May 3, 2023 Direct
transaction MRK Common Stock Tax liability -$32.5K -276 -0.61% $117.89 45.1K May 3, 2023 Direct
transaction MRK Common Stock Options Exercise $112K +949 +2.1% $118.22 46K May 4, 2023 Direct
transaction MRK Common Stock Tax liability -$38.5K -326 -0.71% $118.22 45.7K May 4, 2023 Direct
transaction MRK Common Stock Options Exercise $985K +15.9K +34.73% $62.07 61.6K May 4, 2023 Direct
transaction MRK Common Stock Sale -$1.87M -15.9K -25.78% $117.53 45.7K May 4, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -803 -33.31% $0.00 1.61K May 3, 2023 Common Stock 803 Direct F2, F3
transaction MRK Restricted Stock Unit Options Exercise $0 -949 -49.95% $0.00 951 May 4, 2023 Common Stock 949 Direct F2, F4
transaction MRK Stock Option (Right to Buy) Options Exercise $0 -15.9K -100% $0.00* 0 May 4, 2023 Common Stock 15.9K $62.07 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5000 to $117.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
F4 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
F5 The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.